Literature DB >> 2454888

Lysis of CD3 hybridoma targets by cloned human CD4 lymphocytes.

A Hayward1, A Boylston, P Beverley.   

Abstract

UCHT1, a CD3-producing hybridoma, is lysed by cloned human T cells of both CD4 and CD8 phenotypes. The lysis is specific for the CD3 receptor and is mediated by 90% or more of all T cells from blood, without evidence for a subset of CD4 T cells incapable of cytotoxicity. CD4 clones characterized as 'helper' cells by in vitro help for specific antibody production by B cells also lysed CD3 targets. Varicella zoster virus (VZV) super-infected B lymphoblasts were lysed by three of six VZV-specific T-cell clones and 1 Cl-specific T-cell clones lysed 1 Cl hybridoma targets. Resting B cells (from tonsil) coated with CD3 antibody were lysed by CD4 clones. The data suggest that the majority of clonable CD4+ T cells lyse target cells recognized via CD3 or through the antigen receptor.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2454888      PMCID: PMC1385190     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Different roles for L3T4+ and Lyt 2+ T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system.

Authors:  A A Nash; A Jayasuriya; J Phelan; S P Cobbold; H Waldmann; T Prospero
Journal:  J Gen Virol       Date:  1987-03       Impact factor: 3.891

2.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

3.  Specificity of OKT4+ cytotoxic T lymphocyte clones.

Authors:  A M Krensky; C Clayberger; C S Reiss; J L Strominger; S J Burakoff
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

4.  Delineation of suppressor and helper activity within the OKT4-defined T lymphocyte subset in human newborns.

Authors:  D R Jacoby; M B Oldstone
Journal:  J Immunol       Date:  1983-10       Impact factor: 5.422

Review 5.  Relationship between human T cell functional heterogeneity and human T cell surface molecules.

Authors:  Y Thomas; L Rogozinski; L Chess
Journal:  Immunol Rev       Date:  1983       Impact factor: 12.988

6.  Direct demonstration of the clonogenic potential of every human peripheral blood T cell. Clonal analysis of HLA-DR expression and cytolytic activity.

Authors:  A Moretta; G Pantaleo; L Moretta; J C Cerottini; M C Mingari
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

7.  Distinctive functional characteristics of human "T" lymphocytes defined by E rosetting or a monoclonal anti-T cell antibody.

Authors:  P C Beverley; R E Callard
Journal:  Eur J Immunol       Date:  1981-04       Impact factor: 5.532

8.  Clonal analysis of human cytotoxic T lymphocytes: T4+ and T8+ effector T cells recognize products of different major histocompatibility complex regions.

Authors:  S C Meuer; S F Schlossman; E L Reinherz
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

Review 9.  The differentiation and function of human T lymphocytes.

Authors:  E L Reinherz; S F Schlossman
Journal:  Cell       Date:  1980-04       Impact factor: 41.582

10.  Analysis of the antigen specificity of influenza haemagglutinin-immune human T lymphocyte clones: identification of an immunodominant region for T cells.

Authors:  J R Lamb; N Green
Journal:  Immunology       Date:  1983-12       Impact factor: 7.397

View more
  3 in total

1.  CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.

Authors:  M Azuma; M Cayabyab; D Buck; J H Phillips; L L Lanier
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

2.  Melanoma specific Th1 cytotoxic T lymphocyte lines in Vogt-Koyanagi-Harada disease.

Authors:  K Norose; A Yano
Journal:  Br J Ophthalmol       Date:  1996-11       Impact factor: 4.638

3.  Human T cell responses to beta-galactosidase.

Authors:  J D Oxley; R H Brookes; L S Rayfield; P S Shepherd
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.